
In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

